Madeleine Pharmaceuticals' Series A Round

Madeleine Pharmaceuticals raised a round of funding on February 01, 2011. Investors include Terra Rossa Capital.

Madeleine Pharmaceuticals was spun-out from Hospira's Adelaide operations. Madeleine will commercialise and manufacture a novel treatment for congestive heart failure based on a naturally occurring pe…

Articles about Madeleine Pharmaceuticals' Series A Round: